July/August 2002
CRSToday News

Chief Medical Editor's Page
Weighing the Scales of Justice

C&C Vision Takes Flight
The first accommodating lens is born.

Averting the Diabetic Disaster
Vitreoretinal experts share their tips for improving outcomes in challenging diabetics—including the use of intravitreal triamcinolone acetonide.

Surgical Success With Healon5
Maximizing the benefits of this viscosurgical device during the cataract procedure.

Point/Counterpoint: MMC—Friend or Foe in Refractive Surgery? Part 1
Mitomycin C is a safe and effective adjunct to “high-risk” cases of PRK and LASEK.

Point/Counterpoint: MMC—Friend or Foe in Refractive Surgery? Part 2
The nonselective use of mitomycin C in refractive surgery must be approached cautiously.

Cataract Challenge
Repair of Subluxed Posterior Chamber IOL

Refractive Challenge
Salzmann’s Nodular Degeneration

Anatomy of a Lawsuit
A look inside the trial and $4 million verdict in Stephan Post vs. University Physicians, Inc., Pima County, Superior Court of Arizona, Civil Action No. C20011817.

Defense Claims Dr. Machat “Dropped a Bombshell” in Post vs. UPI Lawsuit
Court grants Defense Motion for Evidentiary Hearing—will the Defense be granted a new trial?

Malpractice Litigation and Refractive Surgery Complications
How do you reduce the legal risks?

The Importance of Pupil Size
When considering refractive surgery, patients with larger pupils should be advised that they are potentially at an increased risk for night glare.

The Best Defense Is a Good Offense
Five steps you can take today to protect yourself and your practice against a lawsuit.

Marketing Mishaps
Are You Experienced?

Ultrasmall-Incision Cataract Surgery
The combination of WhiteStar technology and the ThinOptX lens allows surgeons to perform a familiar cataract procedure through an ultrasmall incision.

Preventing Endophthalmitis
Optimal treatment strategies depend on a surgeon’s preferences and individual patient needs.

Innovations
A preview of today’s new products

5 Questions
Dr. Steve Arshinoff is a pioneer not only in the use of OVDs, but also in various unique outreach programs.